190 related articles for article (PubMed ID: 6296357)
21. A stereochemical explanation of the dopamine agonist and antagonist activity of stereoisomeric pairs.
Froimowitz M; Neumeyer JL; Baldessarini RJ
J Med Chem; 1986 Sep; 29(9):1570-3. PubMed ID: 3746808
[No Abstract] [Full Text] [Related]
22. Specific binding of 3H-guanfacine to alpha 2-adrenoceptors in rat brain. Comparison with 3H-clonidine.
Dausse JP; Cardot A; Meyer P
J Pharmacol; 1983; 14(1):35-46. PubMed ID: 6300560
[TBL] [Abstract][Full Text] [Related]
23. Jejunal-ileal differences in dopaminergic but not alpha-adrenergic antisecretory effects.
Wahawisan R; Gaginella TS; Wallace LJ
Am J Physiol; 1985 Mar; 248(3 Pt 1):G332-6. PubMed ID: 2983568
[TBL] [Abstract][Full Text] [Related]
24. Effects of metyrapone on the pharmacological activity, plasma levels and urinary excretion of the dopamine receptor agonist DK-118.
Koons JC; Long JP; Koble DL; Cannon JG; Fischer LJ
J Pharmacol Exp Ther; 1985 Apr; 233(1):51-7. PubMed ID: 3920384
[TBL] [Abstract][Full Text] [Related]
25. Catecholaminergic activation of G-protein coupling in rat spinal cord: further evidence for the existence of dopamine and noradrenaline receptors in spinal grey and white matter.
Venugopalan VV; Ghali Z; Sénécal J; Reader TA; Descarries L
Brain Res; 2006 Jan; 1070(1):90-100. PubMed ID: 16423330
[TBL] [Abstract][Full Text] [Related]
26. Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists.
Wikström H; Andersson B; Sanchez D; Lindberg P; Arvidsson LE; Johansson AM; Nilsson JL; Svensson K; Hjorth S; Carlsson A
J Med Chem; 1985 Feb; 28(2):215-25. PubMed ID: 3968686
[TBL] [Abstract][Full Text] [Related]
27. Interactions of epinephrine, norepinephrine, dopamine and their corresponding alpha-methyl-substituted derivatives with alpha and beta adrenoceptors in the pithed rat.
Ruffolo RR; Goldberg MR; Morgan EL
J Pharmacol Exp Ther; 1984 Sep; 230(3):595-600. PubMed ID: 6381693
[TBL] [Abstract][Full Text] [Related]
28. The effect of dihydroxy-2-aminotetraline (DATs) on dopamine and beta type adenylate cyclases.
Sheppard H; Burghardt CR; Long JP
Res Commun Chem Pathol Pharmacol; 1978 Feb; 19(2):213-24. PubMed ID: 205926
[TBL] [Abstract][Full Text] [Related]
29. Studies on the adrenergic receptor specificity of inhibitors of phenylethanolamine N-methyltransferase.
Pendleton RG; Hieble JP
Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):399-408. PubMed ID: 6119751
[TBL] [Abstract][Full Text] [Related]
30. Presynaptic effects of 2-aminotetralins on striatal dopaminergic neurons.
Hoffmann IS; Naylor RJ; Cubeddu LX
J Pharmacol Exp Ther; 1980 Nov; 215(2):486-93. PubMed ID: 7441511
[TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationship studies of derivatives of aminotetralins and open chain analogs in relation to beta and alpha-adrenoceptor agonist activities.
Ilhan M; Long JP; Cannon JG
Arch Int Pharmacodyn Ther; 1976 Oct; 223(2):215-22. PubMed ID: 11757
[TBL] [Abstract][Full Text] [Related]
32. Binding of 3H-clonidine to an alpha-adrenoceptor in membranes of guinea-pig ileum.
Tanaka T; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(3):207-15. PubMed ID: 43474
[No Abstract] [Full Text] [Related]
33. Synthesis and pharmacological evaluation of thiazole and isothiazole derived apomorphines.
Sipos A; Mueller FK; Lehmann J; Berényi S; Antus S
Arch Pharm (Weinheim); 2009 Oct; 342(10):557-68. PubMed ID: 19714675
[TBL] [Abstract][Full Text] [Related]
34. 5,7-Dihydroxy-2-aminotetralin derivatives: synthesis and assessment of dopaminergic and adrenergic actions.
Cannon JG; Brubaker AN; Long JP; Flynn JR; Verimer T; Harnirattisai P; Costall B; Naylor RJ; Nohria V
J Med Chem; 1981 Feb; 24(2):149-53. PubMed ID: 7205882
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of 4-substituted 2H-naphth[1,2-b]-1,4-oxazines, a new class of dopamine agonists.
Jones JH; Anderson PS; Baldwin JJ; Clineschmidt BV; McClure DE; Lundell GF; Randall WC; Martin GE; Williams M; Hirshfield JM
J Med Chem; 1984 Dec; 27(12):1607-13. PubMed ID: 6094811
[TBL] [Abstract][Full Text] [Related]
36. Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine.
Lokhandwala MF; Steenberg ML
J Pharmacol Exp Ther; 1984 Jan; 228(1):161-7. PubMed ID: 6694099
[TBL] [Abstract][Full Text] [Related]
37. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the alpha adrenoceptor-mediated effects and antihypertensive activity of ICI 106270: comparison with clonidine.
Ruffolo RR; Yaden EL; Timmermans PB; van Zwieten PA; Hynes MD
J Pharmacol Exp Ther; 1984 Apr; 229(1):58-66. PubMed ID: 6323690
[TBL] [Abstract][Full Text] [Related]
39. Assessment of a potential dopaminergic prodrug moiety in several ring systems.
Cannon JG; Furlano DC; Dushin RG; Chang YA; Baird SR; Soliman LN; Flynn JR; Long JP; Bhatnagar RK
J Med Chem; 1986 Oct; 29(10):2016-20. PubMed ID: 3761320
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacological properties of indolylalkyl derivatives of quipazine].
Trubitsyna TK; Kashkovskiĭ MD
Farmakol Toksikol; 1980; 43(5):530-6. PubMed ID: 7449980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
